Cargando…

The anti-tubercular drug delamanid as a potential oral treatment for visceral leishmaniasis

There is an urgent requirement for safe, oral and cost-effective drugs for the treatment of visceral leishmaniasis (VL). We report that delamanid (OPC-67683), an approved drug for multi-drug resistant tuberculosis, is a potent inhibitor of Leishmania donovani both in vitro and in vivo. Twice-daily o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patterson, Stephen, Wyllie, Susan, Norval, Suzanne, Stojanovski, Laste, Simeons, Frederick RC, Auer, Jennifer L, Osuna-Cabello, Maria, Read, Kevin D, Fairlamb, Alan H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2016
Materias:	Microbiology and Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878867/ https://www.ncbi.nlm.nih.gov/pubmed/27215734 http://dx.doi.org/10.7554/eLife.09744

Ejemplares similares

The R Enantiomer of the Antitubercular Drug PA-824 as a Potential Oral Treatment for Visceral Leishmaniasis
por: Patterson, Stephen, et al.
Publicado: (2013)

Visceral Leishmaniasis in a Non-endemic Region of Eritrea
por: Alamin, Amin A
Publicado: (2020)

Visceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study
por: Huda, M Mamun, et al.
Publicado: (2014)

Unusual Case of Bilateral Tubercular Mastitis
por: Gupta, Archit, et al.
Publicado: (2017)

Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review
por: Wilson, James, et al.
Publicado: (2023)

Aortic Rupture During Surgical Management of Tubercular Spondylodiscitis
por: Yelamarthy, Phani Krishna Karthik, et al.
Publicado: (2018)

Posterior-Only Approach for the Correction of Severe Post-tubercular Kyphosis
por: Toluse, Adetunji, et al.
Publicado: (2023)

A Case of Alveolar-Cell Carcinoma Misdiagnosed As Tubercular Bronchopneumonia
por: Jadhav, Ulhas, et al.
Publicado: (2022)

Clinical features, immunological interactions and household determinants of visceral leishmaniasis and malaria coinfections in West Pokot, Kenya: protocol for an observational study
por: van Dijk, Norbert, et al.
Publicado: (2023)

Assessment of the knowledge, attitude, and practice related to visceral leishmaniasis among residents of Al-Suwaira city, Wasit Governorate, Middle East of Iraq
por: Kanaan, Manal Hadi Ghaffoori, et al.
Publicado: (2022)

Primary Sternal Tubercular Osteomyelitis: A Rare Cause of Chronic Chest Pain
por: Saif, Hani
Publicado: (2021)

Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis
por: Thomas, Michael G., et al.
Publicado: (2020)

Cyclin-dependent kinase 12, a novel drug target for visceral leishmaniasis
por: Wyllie, Susan, et al.
Publicado: (2018)

Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis
por: Thomas, Michael, et al.
Publicado: (2021)

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
por: Wyllie, Susan, et al.
Publicado: (2019)

Leishmaniasis in Cameroon: what is known and is done so far? A protocol for systematic review
por: Djune Yemeli, Linda, et al.
Publicado: (2021)

Self-reported depression and anxiety rates among females with cutaneous leishmaniasis in Hubuna, Saudi Arabia
por: Elfaki, Nahid, et al.
Publicado: (2023)

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis
por: Thomas, Michael G., et al.
Publicado: (2018)

Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol
por: Naeem, Faheel, et al.
Publicado: (2021)

Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani
por: Torrie, Leah S., et al.
Publicado: (2017)

Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity
por: Thomas, Michael G., et al.
Publicado: (2020)

Visceral Leishmaniasis: New Health Tools Are Needed
por: Hailu, Asrat, et al.
Publicado: (2005)

Visceral Leishmaniasis and Arsenic: An Ancient Poison Contributing to Antimonial Treatment Failure in the Indian Subcontinent?
por: Perry, Meghan R., et al.
Publicado: (2011)

DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid
por: Abrahams, Katherine A., et al.
Publicado: (2023)

Microbiota regulates visceral pain in the mouse
por: Luczynski, Pauline, et al.
Publicado: (2017)

Chronic paronychia as a manifestation of skin leishmaniasis
por: dos Santos, Luciana Mendes, et al.
Publicado: (2021)

Association between periorbital cutaneous leishmaniasis and basosquamous carcinoma
por: Grisolia, Danielle Santos, et al.
Publicado: (2021)

Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021)

Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
por: Jones, Deuan C., et al.
Publicado: (2010)

Activation of Bicyclic Nitro-drugs by a Novel Nitroreductase (NTR2) in Leishmania
por: Wyllie, Susan, et al.
Publicado: (2016)

Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei
por: Cleghorn, Laura A. T., et al.
Publicado: (2015)

Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification
por: Wyllie, David H, et al.
Publicado: (2011)

A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada
por: Lang, Raynell, et al.
Publicado: (2018)

Retrospective review of tertiary and neurosyphilis cases in Alberta, 1973–2017
por: Landry, Takaaki, et al.
Publicado: (2019)

Controlled human infection with Neisseria lactamica in late pregnancy to measure horizontal transmission and microbiome changes in mother–neonate pairs: a single-arm interventional pilot study protocol
por: Theodosiou, Anastasia A, et al.
Publicado: (2022)

Protocol for a controlled human infection with genetically modified Neisseria lactamica expressing the meningococcal vaccine antigen NadA: a potent new technique for experimental medicine
por: Gbesemete, Diane, et al.
Publicado: (2019)

Adolescent self-consent for vaccinations: protocol for a mixed methods systematic review
por: Fisher, Harriet, et al.
Publicado: (2018)

Masking by health care and public safety workers in non‐patient care areas to mitigate SARS‐CoV‐2 infection: A systematic review
por: Patterson, P. Daniel, et al.
Publicado: (2022)

Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model
por: de Graaf, Hans, et al.
Publicado: (2017)

Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting
por: Pease, Christopher, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9tdocgp5083f7qflnfk0m0te4t